In particular, recent observations demonstrated that DGAT2 catalyzes the de novo synthesis of triacylglycerols, giving to this enzyme a pivotal role in the development of carbohydrate-induced hypertriglyceridaemia and, consequently, hepatic steatosis. Here, DGAT2 is linked to hypertriglyceridemia.